A pediatric myelodysplastic syndrome with chromosome 5q deletion
Journal: Journal of Cancer Epidemiology & Treatment (Vol.1, No. 2)Publication Date: 2015-09-23
Authors : Hasan Acar Ümran Çalışkan Hüseyin Tokgöz;
Page : 1-4
Keywords : Childhood MDS; Chromosome 5q deletion; Fluorescence in situ hybridization; Chloroma; AML.;
Abstract
Myelodysplastic syndromes (MDS) are rare haematopoietic stem cell diseases in pediatric age group. Pediatric MDS patients have a more progressive course and rapidly transform to acute myeloblastic leukemia (AML). In this study, we report a 3-year- old de novo male pediatric patient who presented with refractory anemia with excess blasts and transformed into acute myelocytic leukemia (AML) in 4 months after the initial diagnosis. At the time of referral, a bone marrow aspirate revealed myelodysplastic changes. Cytogenetic analysis showed the following abnormalities: 46,XY[4]/46,XY,del(5q31)[11] karyotype which was confirmed by FISH analysis. At the follow-up stage, a chloromal lesion occurred at the level of 2 nd lumbar spine. Bone marrow aspiration revealed a leukemic transformation with 40% of myeloblasts. Cytogenetic and FISH analysis showed still the presence of 46,XY,del(5q31)[7]/46,XY,del(5q31),+mar [6] karyotypes. This patient is also the youngest to be reported with RAEB and chromosome 5q deletion and also showed a distinct clinical feature and progression to AML.
Other Latest Articles
- Potential Risks in the Paradigm of Basic to Translational Research: A Critical Evaluation of qPCR Telomere Size Techniques
- Identification of the melanoma stem cell in long-term cultures and SOX6 - as specific biomarker
- Curbing the Costs of Cancer Treatment
- A Need of Metrics in Cancer Economics: Myth or Hope
- Anal squamous cell cancer in African Americans with and without HIV: a comparative study
Last modified: 2018-03-20 13:36:31